Advertisement

August 25, 2026

Dr. Peter Kan to Serve as SNIS President for 2026-2027

KEY TAKEAWAYS

  • Peter Kan, MD, will serve as President of SNIS for the 2026-2027 term.
  • Dr. Kan is an endovascular neurosurgeon and Chair of the Department of Neurosurgery at the University of Texas Medical Branch.
  • Justin Fraser, MD, was named President-Elect, and Jonathan Grossberg, MD, was elected Vice President of SNIS.

August 25, 2026—The Society of NeuroInterventional Surgery (SNIS) announced that Peter Kan, MD, will serve as the 2026-2027 President of the society.

According to SNIS, Dr. Kan is an endovascular neurosurgeon serving as Professor and Robert L. Moody Sr. Chair of the Department of Neurosurgery at the University of Texas Medical Branch in Galveston, Texas.

The SNIS press release noted that Dr. Kan pursued neurosurgical training at the University of Utah in Salt Lake City, Utah. He became a Fellow of the Royal College of Physicians and Surgeons of Canada before starting his endovascular fellowship at the University at Buffalo in Buffalo, New York.

After his fellowship, he joined the faculty at University of South Florida in Tampa, Florida. At South Florida, he served as Director of Cerebrovascular and Endovascular Neurosurgery. He was subsequently recruited as Associate Professor and Director of Cerebrovascular Surgery at Baylor College of Medicine in Houston, Texas.

“Neurointervention continues to advance at an incredible pace, creating new opportunities to improve the lives of patients around the world,” commented Dr. Kan in the society’s press release. “SNIS brings together the brightest minds in our specialty to share knowledge and drive innovation. I am honored to serve as President and look forward to working alongside our members to strengthen our field and continue advancing patient care.”

SNIS also announced that Justin Fraser, MD, an endovascular neurosurgeon at the University of Kentucky in Lexington, Kentucky, is now President-Elect of SNIS. Jonathan Grossberg, MD, an endovascular neurosurgeon at Emory University in Atlanta, Georgia, was elected Vice President.

The 2026-2027 board members are provided in the SNIS press release here.

Advertisement


August 25, 2026

Humacyte’s V007 Phase 3 Hemodialysis Access Trial Results Published


)